Respiratorius is a research company focused on the development of drug candidates for the treatment of cancer, and especially aggressive lymphoma. The company was originally established in 1999 as a spin-off from Lund University. The business is located in Sweden, where research is conducted in-house but also through international partners. The company is headquartered in Lund.

Quotes for Respiratorius AB

Right Now

+/-
-0.3
%
−8,33%
Latest
3.3
High
3.75
Low
3.05
Volume
75 187
Turnover (SEK)
247 221
Market Value (MSEK)
16,8
Time (Latest trade)
2025-09-15 16:19

Board

CEO

  • Johan Drott

Chairperson of the Board

  • Karin Wehlin

Board

  • Johan Drott
  • Kristina Drott
  • Mia Lundblad
  • Articles of association

    • News

    Show More

    News agencies

    Show More

    Analysis

    Videos

    Bolagspresentation och Q&A med Johan Drott

    Johan Drott CEO presenterar på Life Science Day 2019

    Johan Drott CEO, presenterar på Redeye Investor Forum - 10 sep

    Johan Drott, CEO Respiratorius

    Largest Owners

    Name Capital % Votes % Date
    Avanza Pension 9,12 9,12 2025-06-26
    Valcuria Holding AB 3,61 3,61 2025-06-26
    Hans Mandahl 2,16 2,16 2025-06-26
    Nicholas Peebo 1,76 1,76 2025-06-26
    Hartmut Wiese 1,45 1,45 2025-06-26
    Göran Lennart Rehn 1,37 1,37 2025-06-26
    Erik Boström 1,14 1,14 2025-06-26
    Ben Hayes 1,03 1,03 2025-06-26
    Hans Harvig 0,99 0,99 2025-06-26
    Christian Müller 0,98 0,98 2025-06-26
    ** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

    Insider trading

    *Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

    Key Numbers

    *Compiled data from Millistream

    Upcoming reports

    • 2025-11-11 Delårsrapport 2025-Q3

    • 2026-02-10 Bokslutskommuniké 2025

    Annual reports, prospectus etc.